Immuneering Corporation Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Immuneering Corporation (IMRX) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $357.21 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-06
- Immuneering Corporation unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $357.21K, a 18.26% decline from fiscal 2024.
- Immuneering Corporation unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $437.00K, a 175.78% increase from fiscal 2023.
- Immuneering Corporation unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $158.46K, a 1.06% decline from fiscal 2022.
- Immuneering Corporation unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $160.16K, a 22.23% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $357.21K 10-K · filed 2026-03-06 |
| 2024-12-31 | $437.00K 10-K · filed 2026-03-06 |
| 2023-12-31 | $158.46K 10-K · filed 2025-03-20 |
| 2022-12-31 | $160.16K 10-K · filed 2024-03-01 |
| 2021-12-31 | $205.95K 10-K · filed 2023-03-06 |
| 2020-12-31 | $78.00K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |